Sanifit This has been the year of the preclinical biotech cash out: So many early-stage, promising young startups have gone public earlier than ever before. Or they've sold to an opportunistic pharma, sometimes with a big-bucks bet that a platform or asset would be a big mover for its ...
In the spinout, BD shareholders received one share of Embecta’s stock for every five BD shares they held as of March 22. BD didn’t hold on to any ownership stake in its progeny. When trading began on Friday, Embecta—using the ticker symbol “EMBC”—opened at a stock price...